IL27056A - Antitussive composition containing d-3-methoxy-n-methyl-morphinan and process for the manufacture thereof - Google Patents

Antitussive composition containing d-3-methoxy-n-methyl-morphinan and process for the manufacture thereof

Info

Publication number
IL27056A
IL27056A IL27056A IL2705666A IL27056A IL 27056 A IL27056 A IL 27056A IL 27056 A IL27056 A IL 27056A IL 2705666 A IL2705666 A IL 2705666A IL 27056 A IL27056 A IL 27056A
Authority
IL
Israel
Prior art keywords
morphinan
methoxy
methyl
manufacture
composition containing
Prior art date
Application number
IL27056A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL27056A publication Critical patent/IL27056A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL27056A 1966-01-13 1966-12-14 Antitussive composition containing d-3-methoxy-n-methyl-morphinan and process for the manufacture thereof IL27056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52036966A 1966-01-13 1966-01-13

Publications (1)

Publication Number Publication Date
IL27056A true IL27056A (en) 1970-07-19

Family

ID=24072303

Family Applications (1)

Application Number Title Priority Date Filing Date
IL27056A IL27056A (en) 1966-01-13 1966-12-14 Antitussive composition containing d-3-methoxy-n-methyl-morphinan and process for the manufacture thereof

Country Status (10)

Country Link
US (1) US3427379A (xx)
BE (1) BE692250A (xx)
DE (1) DE1617515A1 (xx)
DK (1) DK118301B (xx)
ES (1) ES335565A1 (xx)
FR (1) FR6250M (xx)
GB (1) GB1111173A (xx)
IL (1) IL27056A (xx)
NL (1) NL6700549A (xx)
SE (1) SE338401B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903284A (en) * 1971-10-06 1975-09-02 Denson Fred L Composition containing iminoethanophenanthrene derivatives and method of use
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
US4971798A (en) * 1989-11-30 1990-11-20 Miles Inc. Hard confections containing hydrogenated isomaltulose and medicinally active ingredient
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20050238695A1 (en) * 2004-04-27 2005-10-27 Atma Chaudhari Lozenge for delivery of dextromethorphan
US8668902B2 (en) * 2006-06-08 2014-03-11 Vapor Shield, Inc. Composition with activated carbon in oral treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123528A (en) * 1964-03-03 New therapeutic compositions
US2841528A (en) * 1954-09-21 1958-07-01 Collett & Co As Method of making fused tablets
US2963404A (en) * 1958-09-05 1960-12-06 Pfizer & Co C Tannate candy making, and product
US3012893A (en) * 1959-01-06 1961-12-12 Gen Foods Corp Gasified confection and method of making the same
NL272604A (xx) * 1960-12-28
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US3248290A (en) * 1962-08-09 1966-04-26 Hoffmann La Roche Antitussive compositions
US3282789A (en) * 1963-05-17 1966-11-01 Neisler Lab Inc Stable liquid colloidal tannate compositions
US3341414A (en) * 1964-08-27 1967-09-12 Merck & Co Inc N-cyclohexylsulfamate solubilized medication

Also Published As

Publication number Publication date
GB1111173A (en) 1968-04-24
ES335565A1 (es) 1968-03-16
FR6250M (xx) 1968-08-19
US3427379A (en) 1969-02-11
SE338401B (xx) 1971-09-06
NL6700549A (xx) 1967-07-14
DE1617515A1 (de) 1971-03-18
DK118301B (da) 1970-08-03
BE692250A (xx) 1967-07-06

Similar Documents

Publication Publication Date Title
MY7400317A (en) Halogeno-pregnadienes and process for the manufacture thereof
IL30663A (en) Polyethylene composition and process for the preparation thereof
IL27056A (en) Antitussive composition containing d-3-methoxy-n-methyl-morphinan and process for the manufacture thereof
IL25427A (en) 2-nitro-imidazole derivatives and process for the manufacture thereof
AU427172B2 (en) Composition and process
IL28343A (en) 1-hydroxy-4-carboxymethyl-5-oxohexahydroindane and process for its preparation
CY753A (en) Process for the manufacture of alpha-thyrocalcitonin and beta-thyrocalcitonin
MY7100226A (en) 5-benzylpyrimidine derivatives and process for the preparation thereof
IL27541A (en) Lincomycin-2-acylates and process for their preparation
AU703766A (en) Composition and process
CA958218B (en) glass forming composition and method
MY7000111A (en) Benzenesulphonyl-ureas and process for their manufacture
MY7100058A (en) Benzenesulphonyl-ureas and process for their manufacture
IL28748A (en) N1-isoxazolyl-sulfanilamides and process for the manufacture thereof
CY669A (en) Novel benzodiazepines and process for their manufacture
IL27780A (en) 19-alkylidenesteroids and process for the manufacture thereof
IL24852A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
IL24853A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
IL25794A (en) Phenyl-propylamines and process for their manufacture
CA657411A (en) Antitussive composition and process for the manufacture thereof
IL28712A (en) Phenyltrichloroacetoimidochlorides and process for the preparation thereof
AU440068B2 (en) Chemical composition and process
CA729643A (en) Aminoisoxazoles and process for the manufacture thereof
CA725628A (en) Sulfapyrimidines and process for the manufacture thereof
CA725175A (en) Alkylaminoisoxazoles and process for the manufacture thereof